Cision PR Newswire

AION i60’s Overseas Debut Shows How GAC Is Building Global Competitiveness

JAKARTA, Indonesia, Nov. 13, 2026 /PRNewswire/ -- On November 7, the AION i60 officially launched in Indonesia, marking its overseas debut. This global strategic model had already sold more than 100,000 units in China. As competition intensifies in the global NEV market, the launch gives fresh momentum to GAC's...

Lei Zhang Named TIME100 Climate 2026 Titan for Pioneering Clean Energy Infrastructure for the AI Era

TIME recognition underscores Lei Zhang's leadership in shaping the energy systems for the AI...

Tales of Border Town | “Laogeng” Cross-Border Fair-Going

BEIJING, Nov. 13, 2026 /PRNewswire/ -- A news report from People's Daily: ...

Where Winds Meet 1st Anniversary Launches Today: New ‘Hutuo’ Region Puts the True Spirit of ‘Xia’ to the Test

HANGZHOU, China, Nov. 13, 2026 /PRNewswire/ -- NetEase Games and Everstone Studio today launched Hutuo,...

Weixin Pay Enables Pix QR Code Payments for Chinese Travelers in Brazil

Weixin Pay makes it easier for Chinese visitors to spend at local businesses during...

Unlock the Future of Health and Food Innovation: Hi & Fi Asia-China 2026 Pre-Registration Now Open

SHANGHAI, Jan. 27, 2026 /PRNewswire/ -- Leveraging the solid foundation laid by its highly renowned 2025 edition, Hi & Fi Asia-China, Asia's premier platform...

Thai Researcher Turns Durian Peel Waste into High-Value Sustainable Fiber

BANGKOK, Jan. 27, 2026 /PRNewswire/ -- A doctoral graduate from Chulalongkorn University has developed Thailand's first woven fiber made from discarded durian peels, transforming one of...

Revenera Receives Frost & Sullivan’s 2026 Global Product Leadership Recognition for Excellence in Software Value Chain Enablement

The company is recognized for its market-leading software monetization innovation, end-to-end life cycle enablement, and customer-centric product leadership. SAN ANTONIO, Jan. 27, 2026...

Alphamab Oncology Announces the Results of a Phase III Clinical Study of Anbenitamab (KN026) were Published in Annals of Oncology

SUZHOU, China, Jan. 27, 2026 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment...